Emagene Life, a prominent figure in Asia’s functional medicine and longevity sector, has announced a significant international partnership with the Institute for Functional Medicine (IFM). This collaboration, revealed on 30 September 2025, aims to enhance the practice of functional medicine worldwide by integrating clinical excellence, education, and cross-disciplinary partnerships.
The partnership is set to leverage the strengths of both organisations, with Emagene Life bringing its expertise in longevity and functional medicine, and IFM contributing its 30-year legacy as a leading voice in the field. The alliance is expected to accelerate advancements in AI-driven healthcare, offering innovative solutions to medical challenges.
Emagene Life’s spokesperson highlighted the importance of this collaboration, stating, “This partnership aligns us with the confident and competent practice of functional medicine worldwide.” The integration of artificial intelligence (AI) into healthcare is anticipated to revolutionise patient care, making it more personalised and effective.
The collaboration is not just a milestone for Emagene Life but also a significant step forward in the global healthcare landscape. By combining resources and expertise, the partnership aims to set new standards in functional medicine and longevity, potentially influencing healthcare practices on a global scale.
As the partnership unfolds, both organisations are expected to unveil new initiatives and programmes that will further solidify their commitment to advancing healthcare. This collaboration marks a pivotal moment in the journey towards more integrated and innovative healthcare solutions.
